Cargando…

Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare and highly aggressive malignancy. Surgical resection is the standard treatment for localized ACC, but the local recurrence remains high. Adjuvant radiation (ART) has been proposed as a means to reduce recurrence rates in ACC after surgery with con...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jiawei, Zheng, Ziye, Shen, Jing, Lian, Xin, Miao, Zheng, Shen, Jie, Zhang, Fuquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245885/
https://www.ncbi.nlm.nih.gov/pubmed/32448148
http://dx.doi.org/10.1186/s13014-020-01533-3
_version_ 1783537838702198784
author Zhu, Jiawei
Zheng, Ziye
Shen, Jing
Lian, Xin
Miao, Zheng
Shen, Jie
Zhang, Fuquan
author_facet Zhu, Jiawei
Zheng, Ziye
Shen, Jing
Lian, Xin
Miao, Zheng
Shen, Jie
Zhang, Fuquan
author_sort Zhu, Jiawei
collection PubMed
description BACKGROUND: Adrenocortical carcinoma (ACC) is a rare and highly aggressive malignancy. Surgical resection is the standard treatment for localized ACC, but the local recurrence remains high. Adjuvant radiation (ART) has been proposed as a means to reduce recurrence rates in ACC after surgery with conflicting results from nonrandomized studies. We performed a retrospective study and a meta-analysis to determine the impact of ART on survival outcomes. METHODS: A retrospective study of the adrenocortical cancer database in Peking Union Medical College was conducted. We selected postoperative ACC patients with or without ART. A meta-analysis is also performed to compare the outcomes between ART and only surgical resection in ACC patients. The obtained data were analyzed using SPSS 23.0 and Stata 15.0 statistical software. Differences between two groups were compared using the log-rank test for retrospective analysis and estimated by calculating the odds ratio (OR) and 95% confidence interval (CI) for meta-analysis. RESULTS: Of a total of 75 patients available in the database, 12 patients underwent postoperative ART and were matched one to one to patients with only surgical resection. There was no significant difference on overall survival between ART group and control group (log-rank P = 0.149). Locoregional recurrence was diagnosed in 2 of the ART group, and in 4 of the control group (P = 0.64). A total of 238 participants were selected for the meta-analysis, of which 111 and 127 patients underwent ART after surgical resection and only surgical resection, respectively. Overall survival is significantly higher in ART group, with an odds ratio (OR) of 2.41 (95% CI of 1.33, 4.38; P = 0.004). Besides, meta-analysis significantly favored ART for locoregional recurrence-free survival and disease-free survival, with an OR of 4.08 and 2.27, respectively. CONCLUSIONS: Our results show that compared to only surgical resection, ART is an effective postoperative treatment for ACC.
format Online
Article
Text
id pubmed-7245885
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72458852020-06-01 Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis Zhu, Jiawei Zheng, Ziye Shen, Jing Lian, Xin Miao, Zheng Shen, Jie Zhang, Fuquan Radiat Oncol Research BACKGROUND: Adrenocortical carcinoma (ACC) is a rare and highly aggressive malignancy. Surgical resection is the standard treatment for localized ACC, but the local recurrence remains high. Adjuvant radiation (ART) has been proposed as a means to reduce recurrence rates in ACC after surgery with conflicting results from nonrandomized studies. We performed a retrospective study and a meta-analysis to determine the impact of ART on survival outcomes. METHODS: A retrospective study of the adrenocortical cancer database in Peking Union Medical College was conducted. We selected postoperative ACC patients with or without ART. A meta-analysis is also performed to compare the outcomes between ART and only surgical resection in ACC patients. The obtained data were analyzed using SPSS 23.0 and Stata 15.0 statistical software. Differences between two groups were compared using the log-rank test for retrospective analysis and estimated by calculating the odds ratio (OR) and 95% confidence interval (CI) for meta-analysis. RESULTS: Of a total of 75 patients available in the database, 12 patients underwent postoperative ART and were matched one to one to patients with only surgical resection. There was no significant difference on overall survival between ART group and control group (log-rank P = 0.149). Locoregional recurrence was diagnosed in 2 of the ART group, and in 4 of the control group (P = 0.64). A total of 238 participants were selected for the meta-analysis, of which 111 and 127 patients underwent ART after surgical resection and only surgical resection, respectively. Overall survival is significantly higher in ART group, with an odds ratio (OR) of 2.41 (95% CI of 1.33, 4.38; P = 0.004). Besides, meta-analysis significantly favored ART for locoregional recurrence-free survival and disease-free survival, with an OR of 4.08 and 2.27, respectively. CONCLUSIONS: Our results show that compared to only surgical resection, ART is an effective postoperative treatment for ACC. BioMed Central 2020-05-24 /pmc/articles/PMC7245885/ /pubmed/32448148 http://dx.doi.org/10.1186/s13014-020-01533-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhu, Jiawei
Zheng, Ziye
Shen, Jing
Lian, Xin
Miao, Zheng
Shen, Jie
Zhang, Fuquan
Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis
title Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis
title_full Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis
title_fullStr Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis
title_full_unstemmed Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis
title_short Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis
title_sort efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245885/
https://www.ncbi.nlm.nih.gov/pubmed/32448148
http://dx.doi.org/10.1186/s13014-020-01533-3
work_keys_str_mv AT zhujiawei efficacyofadjuvantradiotherapyfortreatmentofadrenocorticalcarcinomaaretrospectivestudyandanupdatedmetaanalysis
AT zhengziye efficacyofadjuvantradiotherapyfortreatmentofadrenocorticalcarcinomaaretrospectivestudyandanupdatedmetaanalysis
AT shenjing efficacyofadjuvantradiotherapyfortreatmentofadrenocorticalcarcinomaaretrospectivestudyandanupdatedmetaanalysis
AT lianxin efficacyofadjuvantradiotherapyfortreatmentofadrenocorticalcarcinomaaretrospectivestudyandanupdatedmetaanalysis
AT miaozheng efficacyofadjuvantradiotherapyfortreatmentofadrenocorticalcarcinomaaretrospectivestudyandanupdatedmetaanalysis
AT shenjie efficacyofadjuvantradiotherapyfortreatmentofadrenocorticalcarcinomaaretrospectivestudyandanupdatedmetaanalysis
AT zhangfuquan efficacyofadjuvantradiotherapyfortreatmentofadrenocorticalcarcinomaaretrospectivestudyandanupdatedmetaanalysis